RJ

Rajeev Juneja

Active Director Managing Director DIN 00283481 India's Richest · #119
DIN 00283481 First appointment Dec 1992 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 24 active board seats
Past companies 15 historical roles
Total affiliations 39 Since Dec 1992
Shareholding value •••• Premium profile

About Rajeev Juneja

Data last updated:

Rajeev Juneja is a Managing Director at Mankind Pharma Limited (since 1992), Director at Pathkind Diagnostics Private Limited (since 2016) and Director at Appian Multiventures Private Limited (since 2017), and holds 21 more current directorships. The companies operate in Pharma, Healthcare and Financial Services. The 12 current companies with reported revenue have a combined latest revenue of ₹15,044 Cr; the largest is Mankind Pharma Limited at ₹14,636 Cr (FY 2026). Earlier, Rajeev Juneja was a Designated Partner at Saburi Enterprises Llp (2020–2024) and Director at Mahananda Spa And Resorts Private Limited (2015–2024) and 13 more.

Rajeev Juneja and family are #119 among India's richest people (2026), with wealth of ₹27,600 Cr.

DIN 00283481
Primary Designation Managing Director
Industry Pharma
First Appointment 22 Dec 1992
Oldest Company Age 75 yrs
Largest company Mankind Pharma Limited · ₹14,636 Cr (FY 2026)
Combined revenue ₹15,044 Cr across 12 companies

Recognitions & Rankings

India's Richest People 2026 edition · Source: Hurun India
Rank#119
Wealth
₹27,600 Cr
Company
Mankind Pharma
2023 #94 2019 #141 2018 #169

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mankind Pharma Limited L74899DL1991PLC044843
Managing Director22 Dec 19921991₹14,636 Cr (FY 2026)Active
Pathkind Diagnostics Private Limited U74999DL2016PTC306874
Director06 Oct 20162016₹246 Cr (FY 2025)Active
Appian Multiventures Private Limited U70100DL2013PTC251212
Director31 Aug 20172013₹66.25 Cr (FY 2025)Active
Phd Chamber Of Commerce And Industry U74899DL1951NPL001947
Director05 Sep 20231951₹63.29 Cr (FY 2025)Active
Appian Properties Private Limited U24100DL2017PTC321898
Director09 Aug 20172017₹10.80 Cr (FY 2025)Active
Partner27 Aug 20212019₹7.14 Cr (FY 2025)Active
Director16 May 20142006₹6.69 Cr (FY 2025)Active
Director07 Aug 20062005₹4.32 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner15 Sep 20202020Active
Director27 Jul 20152009₹93.40 Cr (FY 2025)Active
V And V Fine Tex Private Limited U74899DL2006PTC146814
Additional Director25 Jan 20072006₹40.9 Lakh (FY 2016)Converted To Llp
Director29 Oct 20102003₹10.42 Cr (FY 2025)Active
Sirmour Remedies Private Limited U15311HP1989PTC009770
Director22 Aug 20051989₹98.10 Cr (FY 2025)Active
Moksha Estates Private Limited U70101DL1996PTC080289
Director01 Aug 20021996Strike Off
Director21 Jul 20112006₹2.02 Cr (FY 2025)Active
Director14 Sep 20202020₹90.12 Cr (FY 2025)Active
Lifestar Pharma Private Limited U24232DL2004PTC131232
Director14 Dec 20042004₹265 Cr (FY 2022)Amalgamated
Magnet Labs Private Limited U51397DL1998PTC093307
Director01 May 20171998₹301 Cr (FY 2022)Amalgamated
Rekhi Steels Pvt Ltd U74899DL1973PTC006492
Director20 Jul 20041973Strike Off
Jaspack Industries Private Limited U36912DL2015PTC277915
Director16 Mar 20152015₹3.65 Cr (FY 2024)Amalgamated
Bharat Serums And Vaccines Limited U74110MH1993PLC075088
Director23 Oct 20241993₹1,557 Cr (FY 2026)Under Liquidation

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Rajeev Juneja

NameDINCompanyDesignation
Anish Vanraj Bafna02925792Mankind Pharma LimitedDirector
Ashutosh DhawanMankind Pharma LimitedCfo
Hitesh Kumar JainMankind Pharma LimitedCompany Secretary
Ramesh Juneja00283399Mankind Pharma Limited , Appian Associates Infrastructure Private Limited and 4 moreWhole-Time Director
Satish Kumar Sharma07615602Mankind Pharma Limited , Appian Properties Private Limited and 1 moreWhole-Time Director
Sheetal AroraMankind Pharma LimitedCeo
Sheetal Arora00704292Mankind Pharma Limited , Pathkind Diagnostics Private Limited and 13 moreWhole-Time Director
Tilokchand Punamchand Ostwal00821268Mankind Pharma LimitedDirector
Vijaya Sampath00641110Mankind Pharma LimitedDirector
Vivek Kalra00426240Mankind Pharma Limited , Kindcare FoundationDirector
Arjun Juneja00704349Pathkind Diagnostics Private Limited , Appian Multiventures Private Limited and 11 moreDirector
Eklavya Juneja06754247Pathkind Diagnostics Private Limited , Anm Properties Private LimitedWhole-Time Director
Rohit Brijmohan Mantri07435803Pathkind Diagnostics Private LimitedNominee Director
Sanjeev Vashishta01457971Pathkind Diagnostics Private LimitedManaging Director
Sanjeev VashishtaPathkind Diagnostics Private LimitedCeo
Shibu ShresthaPathkind Diagnostics Private LimitedCompany Secretary
Surendra Lunia00121156Pathkind Diagnostics Private LimitedDirector
Abhinav DoraAppian Multiventures Private LimitedCompany Secretary
Aditi Pasari00120753Phd Chamber Of Commerce And IndustryDirector
Ajaya Behari Lal Srivastava01601682Phd Chamber Of Commerce And IndustryDirector
Ajit Kumar Gupta00019393Phd Chamber Of Commerce And IndustryDirector
Alka Batra00769350Phd Chamber Of Commerce And IndustryDirector
Amar Sarin00015937Phd Chamber Of Commerce And IndustryDirector
Amit Nenwani02285473Phd Chamber Of Commerce And IndustryAdditional Director
Amith Jain10550536Phd Chamber Of Commerce And IndustryAdditional Director

Directorship timeline

Open interactive timeline →
Complete Circle Wealth Solutions Llp
Appian Multiventures Private Limited
Lifestar Pharma Private Limited
Saburi Sai Ram Buildtech Private Limited
Premium access

Shareholding and investment profile for Rajeev Juneja

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajeev Juneja

Rajeev Juneja currently holds 24 directorships: Mankind Pharma Limited (Managing Director, since 22 Dec 1992, revenue ₹14,636 Cr (FY 2026)); Pathkind Diagnostics Private Limited (Director, since 06 Oct 2016, revenue ₹246 Cr (FY 2025)); Appian Multiventures Private Limited (Director, since 31 Aug 2017, revenue ₹66.25 Cr (FY 2025)); Phd Chamber Of Commerce And Industry (Director, since 05 Sep 2023, revenue ₹63.29 Cr (FY 2025)); Appian Properties Private Limited (Director, since 09 Aug 2017, revenue ₹10.80 Cr (FY 2025)); and 19 more.

Rajeev Juneja was first appointed on 22 Dec 1992 as Managing Director at Mankind Pharma Limited. The most recent appointment on record is 02 Jun 2025 at Kindcare Foundation.

The 12 current companies of Rajeev Juneja that report revenue have a combined latest revenue of ₹15,044 Cr: Mankind Pharma Limited ₹14,636 Cr (FY 2026); Pathkind Diagnostics Private Limited ₹246 Cr (FY 2025); Appian Multiventures Private Limited ₹66.25 Cr (FY 2025); Phd Chamber Of Commerce And Industry ₹63.29 Cr (FY 2025); Appian Properties Private Limited ₹10.80 Cr (FY 2025); and 7 more.

Rajeev Juneja held 15 earlier board appointments: Saburi Enterprises Llp (Designated Partner, 15 Sep 2020 to 08 Aug 2024); Mahananda Spa And Resorts Private Limited (Director, 27 Jul 2015 to 17 May 2024); V And V Fine Tex Private Limited (Additional Director, 25 Jan 2007 to 15 Sep 2009); Broadway Hospitality Services Private Limited (Director, 29 Oct 2010 to 26 Dec 2017); Sirmour Remedies Private Limited (Director, 22 Aug 2005 to 31 Jul 2009); and 10 more.

The current boards of Rajeev Juneja's companies include Anish Vanraj Bafna (Mankind Pharma Limited), Ashutosh Dhawan (Mankind Pharma Limited), Hitesh Kumar Jain (Mankind Pharma Limited), Ramesh Juneja (Mankind Pharma Limited), Satish Kumar Sharma (Mankind Pharma Limited), Sheetal Arora (Mankind Pharma Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available